Gene Patents and Collaborative Licensing Models

Patent Pools, Clearinghouses, Open Source Models and Liability Regimes
Herausgeber: Overwalle, Geertrui van

• Gebundenes Buch

Produktbeschreibung

An examination of legal measures which might be used to solve the problem of fragmentation of patents in genetics.

Produktdetails

• Verlag: Cambridge University Press
• Seitenzahl: 516
• Erscheinungstermin: 28. Juni 2012
• Englisch
• Abmessung: 235mm x 157mm x 32mm
• Gewicht: 890g
• ISBN-13: 9780521896733
• ISBN-10: 0521896738
• Artikelnr.: 26056643

Inhaltsangabe

Part I. Patent Pools: 1. Patent pooling for gene-based diagnostic testing:
conceptual framework Birgit Verbeure; 2. Case 1. The MPEG LA® licensing
model. What problem does it solve in biopharma and genetics? Lawrence A.
Horn; 3. Case 2. IP fragmentation and patent pools: the SARS case Carmen E.
Correa; 4. Critical analysis of patent pools Jorge A. Goldstein; Part II.
Clearing Houses: 5. Clearinghouse mechanisms in genetic diagnostics:
conceptual framework Esther van Zimmeren; 6. Case 3. The global
biodiversity information facility. An example of an information
clearinghouse James L. Edwards; 7. Case 4. BirchBob: an example of a
technology exchange clearing house Esther van Zimmeren and Dirk Avau; 8.
Case 5. The public intellectual property resource for agriculture. A
standard license public sector clearinghouse for agricultural IP Alan B.
Bennett and Sara Boettiger; 9. Case 6. The science commons material
transfer agreement project. A standard license clearing house? Thinh
Nguyen; 10. Case 7. The collective management of copyright and neighbouring
rights. An example of a royalty collection clearing house Jan Corbet; 11.
Comment on the conceptual framework for a clearing house mechanism Michael
Spence; Part III. Open Source: 12. Open source genetics: a conceptual
framework Janet Hope; 13. Case 8. CAMBIA's biological open source
initiative (BiOS) Nele Berthels; 14. Case 9. Diversity Arrays Technology
Pty Ltd.: applying the open source philosophy in agriculture Andrzej
Kilian; 15. Critical commentary on 'open source' in the life sciences Arti
K. Rai; 16. Several kinds of 'should': the ethics of open source in life
sciences innovation Antony Taubman; Part IV. Liability Regimes: 17.
Pathways across the valley of death: novel intellectual property strategies
for accelerated drug discovery Arti K. Rai, Jerome H. Reichman, Paul F.
Uhlir and Colin Crossman; 18. Case 10. The international treaty on plant
genetic resources for food and agriculture: the standard material transfer
agreement as implementation of a limited compensatory liability regime
Victoria Henson-Apollonio; 19. Critical analysis of property rules,
liability rules and molecular futures: bargaining in the shadow of the
cathedral Dan L. Burk; Part V. Different Perspectives: 20. Gene patents:
from discovery to invention. A geneticist's view Gert Matthijs and Gert-Jan
Van Ommen; 21. 'Patent Tsunami' in the field of genetic diagnostics. A
patent practitioner's view Jacques Warcoin; 22. Gene patents and clearing
models. Some comments from a competition law perspective Hanns Ullrich; 23.
Access to genetic patents and clearinghouse model. An economic perspective
Reiko Aoki; 24. The role of law, institutions and governance in
facilitating access to the scientific research commons. A philosopher's
perspective Tom Dedeurwaerdere; Part VI. Concluding Thoughts: 25. Of
thickets, blocks and gaps: designing tools to resolve obstacles in the gene
patents landscape Geertrui van Overwalle.